Literature DB >> 18722786

Regulatory T cells in health and disease.

Ciriaco A Piccirillo1.   

Abstract

Regulatory T (Treg) cells have emerged as a central control point in the modulation of various immune responses, including autoimmune responses and immunity to transplants, allergens, tumors, and infectious microbes. The immune system has evolved complex processes to ensure tolerance to autoantigens while preserving the potential to mount and maintain life-long humoral and cellular immune responses against invading pathogens. In this review, we summarize research showing that naturally occurring (nTreg) and induced Treg (iTreg) cell subsets, and in particular CD4+Foxp3+ Treg cells, are critical in the control of immune responses in rodents and humans. We also discuss the cellular and molecular factors that affect CD4+Foxp3+ Treg cell development, homeostasis, and function and consequential immunity to self and non-self antigens. Recent studies have shed light in our understanding of the development of novel methods of autoimmune disease prevention and treatment via enhancing and re-establishing Treg-mediated dominant control over self-reactive T cells in animal models and humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722786     DOI: 10.1016/j.cyto.2008.07.469

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

1.  Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep.

Authors:  Steffen Kunzmann; Kerstin Glogger; Jasper V Been; Suhas G Kallapur; Ilias Nitsos; Timothy J Moss; Christian P Speer; John P Newnham; Alan H Jobe; Boris W Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.

Authors:  A Hoerning; S Köhler; C Jun; J Lu; J Fu; B Tebbe; S Dolff; T Feldkamp; A Kribben; P F Hoyer; O Witzke
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

Review 3.  The short-term stress response - Mother nature's mechanism for enhancing protection and performance under conditions of threat, challenge, and opportunity.

Authors:  Firdaus S Dhabhar
Journal:  Front Neuroendocrinol       Date:  2018-03-26       Impact factor: 8.606

4.  Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.

Authors:  Youmin Zhong; Angelene Cantwell; Peter H Dube
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

Review 5.  Effects of stress on immune function: the good, the bad, and the beautiful.

Authors:  Firdaus S Dhabhar
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.

Authors:  Sara M Centuori; Malika Trad; Collin J LaCasse; Darya Alizadeh; Claire B Larmonier; Neale T Hanke; Jessica Kartchner; Nona Janikashvili; Bernard Bonnotte; Nicolas Larmonier; Emmanuel Katsanis
Journal:  J Leukoc Biol       Date:  2012-08-13       Impact factor: 4.962

7.  Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1.

Authors:  Urmila Maitra; Sarah Davis; Christopher M Reilly; Liwu Li
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  Impairment of regulatory T-cell function in autoimmune thyroid disease.

Authors:  Abigail B Glick; Alaina Wodzinski; Pingfu Fu; Alan D Levine; David N Wald
Journal:  Thyroid       Date:  2013-07       Impact factor: 6.568

9.  Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.

Authors:  Katy Milne; Martin Köbel; Steven E Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

10.  The danger is growing! A new paradigm for immune system activation and peripheral tolerance.

Authors:  Sharon Bewick; Ruoting Yang; Mingjun Zhang
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.